CompaniesMaxivax

Maxivax

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

50

By Phase

NA: 1PHASE1: 1

By Status

COMPLETED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT02193503
NCT02999646
Hover over trial bars to see details

Recent Trials

NCT02999646Lead Sponsor
Personalized and Cell-based Antitumor Immunization MVX-ONCO-1 in Advanced HNSCC
NACompleted
16 participants
Started: Jul 25, 2018 · Completed: Jun 29, 2023
NCT02193503Lead Sponsor
MVX-ONCO-1 in Patients With Solid Tumor
PHASE1Active, not recruiting
34 participants
Started: Mar 31, 2014 · Completed: Dec 31, 2026